טוען...
The Gut Microbiome and Response to Cardiovascular Drugs
The gut microbiome is emerging as an important contributor to both cardiovascular disease risk and metabolism of xenobiotics. Alterations in the intestinal microbiota are associated with atherosclerosis, dyslipidemia, hypertension and heart failure. The microbiota have the ability to metabolize medi...
שמור ב:
| הוצא לאור ב: | Circ Genom Precis Med |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6751004/ https://ncbi.nlm.nih.gov/pubmed/31462078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCGEN.119.002314 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|